Skip to main content
Skip to navigation

Pfizer Agrees to $60 Million in Settlements Amid Foreign Bribery Charges

By Joe Mont2012-08-07T13:09:00

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

Related articles

Article
Pfizer facing FCPA probes into China operations

2020-11-09T20:21:00Z By Jaclyn Jaeger

Pharmaceutical firm Pfizer announced in a recent regulatory filing that it has received requests from the Department of Justice and the Securities and Exchange Commission regarding the company’s operations in China.
Article
Special report: Are FCPA actions merely a slap on the wrist?

2016-04-12T14:15:00Z By Jaclyn Jaeger

Companies on the receiving end of an FCPA enforcement action often face monitoring, fines, and litigation as a result. But many times, what they don’t experience is a drop in their share price. In fact, among the largest FCPA violations on record, many companies saw no drop in share price. ...